Moreover, CDK4 is found to be highly expressed in aggressive tumors and its expression correlate with poor overall and relapse-free survival outcomes as well as poor prognostic features of breast cancer patients, suggesting a central role for this protein in cancer development and progression (Massague 2004). Here, CDK4 is linked to breast carcinoma.